Clarity AD - Mild Cognitive Impairment / Early Alzheimer’s Disease Research Study

    Not Recruiting
Updated on 3 March 2021
cognitive impairment
mild cognitive impairment


The Memory Health Center at Summit Research Network, is enrolling participants in the Clarity AD Research Study.  This research study will evaluate whether an investigational study drug is safe and effective in slowing the progression of Alzheimer’s.

Study participation may last to up 23 months with the option to participate in an extension for another 24 months. Following a screening period of up to 2 months, qualified participants will be randomly assigned to receive either the intravenous investigational study drug, , or a placebo (an inactive substance) and enter into an 18 month treatment period.  During the treatment period, the participants will visit the research center every 2 weeks to receive the study drug or placebo. 

Additional memory and safety assessments will be completed during the visits at specified time points throughout the study. 

At the end of the 18 month treatment period, those entering the optional open-label study extension, will receive the investigational study drug, and visit the study center every 2 weeks for the study visit. Participants who do not enter the open label study extension, will attend a follow-up visit 3 months after their final study visit.



Study-related neuro-psychological evaluation, neurological and physical exams, laboratory tests, ECG, and brain scans are provided to research study participants at designated time points during screening and throughout the trial.
As with all studies at the Memory Health Center, if you qualify and participate you will receive study related testing and care as well as travel reimbursement.

Condition Alzheimer's Disease
Clinical Study IdentifierTX235494
Last Modified on3 March 2021

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note